 |
Trials |
An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of Modufolin® in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal CancerCancer type: Colorectal cancer Phase: I/II Principal Investigator: Guren Tormod Country: NO Keywords: Norway, Oslo, Colorectal cancer, Modufolin Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02244632?term=2014-001862-84&rank=1 |